Head-to-Head

Amgen Inc vs. Halozyme Therapeutics, Inc.

AMGN

Amgen Inc

$463.02 -0.64%

VS HALO

Halozyme Therapeutics, Inc.

$128.11 -2.14%

Amgen Inc (AMGN) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AMGNHALO
Market Cap $251.94 billion $14.86 billion

AMGN leads on 1 of 1 size & scale factors.

Dividend

AMGNHALO
Dividend Yield 2.18% —

AMGN and HALO split the dividend factors evenly.

Risk & Sentiment

AMGNHALO
Short Interest 1.66% 9.79%

AMGN leads on 1 of 1 risk & sentiment factors.

Dig deeper: AMGN overview, AMGN financials, HALO overview, HALO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.